Home › Funds › Avoro Capital Advisors LLC › BHVN

Avoro Capital Advisors LLC position in BHVN

BIOHAVEN LTD · Health Care

Avoro Capital Advisors LLC reported holding 2,750,000 shares of BHVN (BIOHAVEN LTD) in its Q3 2026 13F filing — a position valued at US$36.7M, representing 0.38% of its reported portfolio and ranking #26 among its reported holdings. Avoro Capital Advisors LLC first reported this position in Q3 2026.

Latest position (Q3 2026)2.75M sh
Reported value held$36.71M
Portfolio Weight0.38%
First reportedQ3 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Avoro Capital Advisors LLC's BHVN position evolved

Avoro Capital Advisors LLC first disclosed a stake in BHVN in Q3 2026 at 2,750,000 shares (US$36.7M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 2.75M $36.71M New

About BHVN and 13F data

BHVN (BIOHAVEN LTD) is a Health Care company. 27 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$39.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BHVN

All BHVN fund holders →

FAQ

How long has Avoro Capital Advisors LLC held BHVN?

Avoro Capital Advisors LLC has disclosed BHVN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Avoro Capital Advisors LLC's current position in BHVN?

As of Q3 2026, Avoro Capital Advisors LLC holds 2.75M shares of BHVN (BIOHAVEN LTD), valued at $36.71M, representing 0.38% of its reported portfolio and ranking #26.

Has Avoro Capital Advisors LLC been buying or selling BHVN?

In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC newly opened its position in BHVN.

Which other funds hold BHVN?

Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.